Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
71.35 CHF | +2.07% | +11.34% | +38.90% |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day | |
Mar. 20 | Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.90% | 1.24B | |
+35.62% | 701B | |
+26.24% | 571B | |
+1.21% | 381B | |
+20.89% | 334B | |
+17.04% | 319B | |
+1.00% | 210B | |
+2.77% | 210B | |
-6.11% | 201B | |
-3.20% | 157B |
- Stock
- Equities
- Stock Cosmo Pharmaceuticals N.V. - Swiss Exchange
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals' GI Genius Device Cuts Adenoma, Polyp Miss Rate in Colonoscopy